Pauls Matthewinsider trades
In SEC Form 4 filings, Pauls Matthew is listed as Director of Pelthos Therapeutics Inc. (PTHS). In the last 90 days, Pauls Matthew sold $16.5K of Pelthos Therapeutics Inc. (PTHS) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| PTHSPelthos Therapeutics Inc. | Director | 1 | Oct 6 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-06
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.